Followers

0
0
0
0
.
8
8
4
4
4
4
,
1
1
-9.70 (-0.67%)

As on 28 Oct, 2025 | 11:47

Open Trading A/c
Day Range
1,446.50
1,468.30
LH
52 Week Range
1,345.00
2,451.70
LH
Volume
* i
Bid / Ask
20,546.00
1,448.00 / 73.00

Concord Biotech Announcements

Intimation of Successful Completion of NAFDAC Inspection at our Oral Solid Dosage Unit-2, facility located at Valthera

08 Oct, 2025 | 11:04am • Source: BSE

Enclosed herewith the certificate under Regulation 74(5) of the SEBI(DP) regulations, 2018 for the quarter ended 30.09.2025

06 Oct, 2025 | 05:16pm • Source: BSE

Concord Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

25 Sep, 2025 | 10:07am • Source: NSE

Intimation of Trading Window Closure

25 Sep, 2025 | 10:02am • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 19th September, 2025 at 11:00...

11 Sep, 2025 | 03:18pm • Source: BSE

Intimation of Schedule of Analyst / Institutional Investor meetings under the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015 on 17th September, 2025 at 10:00...

11 Sep, 2025 | 03:14pm • Source: BSE

Concord Biotech Limited has informed the Exchange about Schedule of meet

11 Sep, 2025 | 03:13pm • Source: NSE

Concord Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 09, 2025

11 Sep, 2025 | 03:08pm • Source: NSE

Pursuant to provision 44(3) of SEBI LODR, 2015 Please find enclosed herewith details of Voting result of 40thAGM and Scrutinizer''s Report on E-voting.

11 Sep, 2025 | 02:49pm • Source: BSE

Regulation 30 of the SEBI (LODR) Regulation, 2015, we hereby enclose the summary of the proceedings of AGM held on Tuesday, 9 September, 2025 through...

09 Sep, 2025 | 05:53pm • Source: BSE

Concord Biotech Limited has informed the Exchange about General Updates- Successful Completion Of EU GMP Inspection

21 Aug, 2025 | 02:50pm • Source: NSE

Intimation of successful completion of European Union Good Manufacturing Practices (EU GMP) inspection at our API facility in Limbassi

21 Aug, 2025 | 02:12pm • Source: BSE

Transcript of Q1FY26 Earning call held on August 11, 2025

18 Aug, 2025 | 06:14pm • Source: BSE

Enclosed herewith BRSR for FY 2024-2025

13 Aug, 2025 | 02:41pm • Source: BSE

Concord Biotech Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 09, 2025

13 Aug, 2025 | 11:53am • Source: NSE

Annual report- Disclosure under Regulation 34 of SEBI(LODR) Regulation, 2015

13 Aug, 2025 | 11:38am • Source: BSE

40th Annual general Meeting to be held on 9th September, 2025 at 4:00 PM through OAVM

13 Aug, 2025 | 11:30am • Source: BSE

Newspaper Advertisement Clipping for 40th Annual General Meeting, Record date for Dividend and E-Voting Information

12 Aug, 2025 | 02:42pm • Source: BSE

Q1FY26 Earnings Call Audio

11 Aug, 2025 | 06:31pm • Source: BSE

Investor Presentation on Financial Results for the Q1 FY25-26

10 Aug, 2025 | 12:44pm • Source: BSE